Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board
Degrading the drivers of disease Reversing the course of disease
Restored homeostasis after autophagy induction
Genetic model of liver disease
Degrading the drivers of disease Reversing the course of disease
Restored homeostasis after autophagy induction
Genetic model of muscle disease
Degrading the drivers of disease Reversing the course of disease
Restored homeostasis after autophagy induction
Animal model of liver disease
Pioneering the next generation of targeted degradation by harnessing the power of the autophagy pathway.
The Power of Autophagy
Autophagy is a major cellular degradation pathway that has unrealized potential for therapeutic development.
READ MORE
Our Therapeutic Focus
Translating autophagy insights into new treatments for patients with unmet medical needs including rare genetic diseases and broad pathologies.
READ MORE
The People of Casma
Driven to uncover the role of autophagy in disease, and to accelerate these insights into breakthroughs for patients.
READ MORE